The functionally relevant site for paxilline inhibition of BK channels

Proceedings of the National Academy of Sciences
2020.0

Abstract

The tremorgenic fungal alkaloid paxilline (PAX) is a commonly used specific inhibitor of the large-conductance, voltage- and Ca(2+)-dependent BK-type K(+) channel. PAX inhibits BK channels by selective interaction with closed states. BK inhibition by PAX is best characterized by the idea that PAX gains access to the channel through the central cavity of the BK channel, and that only a single PAX molecule can interact with the BK channel at a time. The notion that PAX reaches its binding site via the central cavity and involves only a single PAX molecule would be consistent with binding on the axis of the permeation pathway, similar to classical open channel block and inconsistent with the observation that PAX selectively inhibits closed channels. To explore the potential sites of interaction of PAX with the BK channel, we undertook a computational analysis of the interaction of PAX with the BK channel pore gate domain guided by recently available liganded (open) and metal-free (closed) Aplysia BK channel structures. The analysis unambiguously identified a preferred position of PAX occupancy that accounts for all previously described features of PAX inhibition, including state dependence, G311 sensitivity, stoichiometry, and central cavity accessibility. This PAX-binding pose in closed BK channels is supported by additional functional results.

Knowledge Graph

Similar Paper

The functionally relevant site for paxilline inhibition of BK channels
Proceedings of the National Academy of Sciences 2020.0
Analgesic Buxus alkaloids with Enhanced Selectivity for the Low‐Voltage‐Gated Calcium Channel Ca<sub>v</sub>3.2 over Ca<sub>v</sub>3.1 through a New Binding Mode
Angewandte Chemie International Edition 2024.0
Partial structures of ketoconazole as modulators of the large conductance calcium-activated potassium channel (BKCa)
Bioorganic &amp; Medicinal Chemistry Letters 2006.0
Discovery of an Inhibitor for the TREK-1 Channel Targeting an Intermediate Transition State of Channel Gating
Journal of Medicinal Chemistry 2020.0
Large conductance Ca2+-activated K+ channel (BKCa) activating properties of a series of novel N-arylbenzamides: Channel subunit dependent effects
Bioorganic &amp; Medicinal Chemistry 2013.0
Synthesis of and radioligand binding studies with a tritiated pinacidil analog: receptor interactions of structurally different classes of potassium channel openers and blockers
Journal of Medicinal Chemistry 1993.0
A Structural Rationale for N‐Methylbicuculline Acting as a Promiscuous Competitive Antagonist of Inhibitory Pentameric Ligand‐Gated Ion Channels
ChemBioChem 2020.0
The structure of paxilline, a tremorgenic metabolite of bainier
Tetrahedron Letters 1975.0
Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: Evidence for interaction at the diltiazem-binding site
Biochemistry 1992.0
A Rational Design of a Selective Inhibitor for Kv1.1 Channels Prevalent in Demyelinated Nerves That Improves Their Impaired Axonal Conduction
Journal of Medicinal Chemistry 2017.0